676 related articles for article (PubMed ID: 6705265)
1. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
Adu D; Williams DG
Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
[TBL] [Abstract][Full Text] [Related]
2. Regulation of immune complex-mediated complement activation by autoantibodies (F-42) isolated from sera of patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Vanes LA
Clin Exp Immunol; 1983 Sep; 53(3):541-6. PubMed ID: 6604604
[TBL] [Abstract][Full Text] [Related]
3. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
4. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
Perrin LH; Lambert PH; Miescher PA
J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
[TBL] [Abstract][Full Text] [Related]
5. Activation of the alternative complement pathway in systemic lupus erythematosus.
Wilson MR; Arroyave CM; Nakamura RM; Vaughan JH; Tan EM
Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
[TBL] [Abstract][Full Text] [Related]
6. DNA-anti-DNA circulating complexes in the nephritis of systemic lupus erythematosus.
Adu D; Dobson J; Williams DG
Clin Exp Immunol; 1981 Mar; 43(3):605-14. PubMed ID: 6974627
[TBL] [Abstract][Full Text] [Related]
7. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
8. Serum factors activating the alternative complement pathway in autoimmune disease: description of two different factors from patients with systemic lupus erythematosus.
Arroyave CM; Wilson MR; Tan EM
J Immunol; 1976 Mar; 116(3):821-6. PubMed ID: 815434
[TBL] [Abstract][Full Text] [Related]
9. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
10. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
[TBL] [Abstract][Full Text] [Related]
11. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
12. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
13. Cryoglobulin studies in systemic lupus erythematosus.
Sikander F; Salgaonkar DS; Joshi VR
J Postgrad Med; 1989 Jul; 35(3):139-43. PubMed ID: 2634754
[TBL] [Abstract][Full Text] [Related]
14. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
[TBL] [Abstract][Full Text] [Related]
15. Solubilization of immune complexes and inhibition of immune precipitation in SLE sera.
Balestrieri G; Pagani D; Tincani A
J Clin Lab Immunol; 1983 Nov; 12(3):147-50. PubMed ID: 6663608
[TBL] [Abstract][Full Text] [Related]
16. Complement fixing properties of antibodies to double-stranded DNA in systemic lupus erythematosus.
Gharavi AE; Elkon KB; Schifferli JA; Hughes GR
J Clin Lab Immunol; 1981 Nov; 6(3):251-5. PubMed ID: 7338885
[TBL] [Abstract][Full Text] [Related]
17. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
[TBL] [Abstract][Full Text] [Related]
18. Determination of circulating immune complexes, C3 and C4 complement components and anti-DNA antibody in different classes of lupus nephritis.
Klein MH; Thorner PS; Yoon SJ; Poucell S; Baumal R
Int J Pediatr Nephrol; 1984 Jun; 5(2):75-82. PubMed ID: 6333404
[TBL] [Abstract][Full Text] [Related]
19. Complement deficiencies and systemic lupus erythematosus.
Truedsson L; Bengtsson AA; Sturfelt G
Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
